$10.090
-0.080 (-0.79%)收盤時
價格預測
在 App 中開啟以解鎖更長週期的預測。
BCRX 相似圖表分析預測
Alphio's BCRX stock price prediction model matches the current BioCryst Pharmaceuticals, Inc. tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $10.04 (-0.53%). The 1-week path is $9.58 (-5.09%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.
該買進 BioCryst Pharmaceuticals, Inc. 股票嗎？
BioCryst Pharmaceuticals appears to be a good buy right now due to its strong revenue growth and profitability outlook. The company expects Orladeyo sales to reach between $625 million and $645 million for 2023, contributing to a total revenue of over $2 billion since its U.S. approval. Additionally, the stock has shown a year-to-date increase of 30.93%, reflecting positive market sentiment. However, a risk to consider is the negative net income reported for Q1 2026, which was -721.81 million USD, highlighting potential volatility in earnings.
BCRX 股價於 Thursday 收在 $10.09，此前下跌 -0.79%
BioCryst Pharmaceuticals, Inc. (BCRX) last closed at $10.09, losing -0.79%. These facts feed the 1-day and 1-week BCRX price prediction above.
預測驅動因素
BioCryst Pharmaceuticals, Inc.（BCRX）的預測驅動因素綜合了相似的圖表形態、季節性與移動平均線。
Similar patterns
Bullish
Seasonality
Bullish
SMA 20
Bullish
SMA 200
Bullish
相似圖表形態
近期走勢與 BCRX 最接近的股票，依相似度排序。
BCRX 季節性分析
Historically the probability of a positive September return for BCRX is 77.27%. July offers the highest probability of a positive month at 100.00%, while January is the weakest seasonal window. Alphio blends this calendar with technical signals and similar chart pattern matching before it writes the forecast.
BCRX 十年價格預測
| 月份 | 最低價 | 平均價 | 最高價 | 潛在報酬率 |
|---|---|---|---|---|
| Sep 2026 | $13.91 | $15.24 | $16.69 | +51.05% |
| Oct 2026 | $16.05 | $16.54 | $19.80 | +63.94% |
| Nov 2026 | $12.53 | $14.03 | $16.10 | +39.06% |
| Dec 2026 | $15.40 | $17.17 | $18.22 | +70.15% |
2026 年，BioCryst Pharmaceuticals, Inc.（BCRX）預計區間為 $12.53 至 $19.80。
BioCryst Pharmaceuticals, Inc. 2026 年月度預測
2026 年 Sep，BioCryst Pharmaceuticals, Inc. 預計均價 $15.24，最低 $13.91，最高 $16.69。
2026 年 Oct，BioCryst Pharmaceuticals, Inc. 預計均價 $16.54，最低 $16.05，最高 $19.80。
2026 年 Nov，BioCryst Pharmaceuticals, Inc. 預計均價 $14.03，最低 $12.53，最高 $16.10。
2026 年 Dec，BioCryst Pharmaceuticals, Inc. 預計均價 $17.17，最低 $15.40，最高 $18.22。
本頁僅供研究參考，不構成投資建議。模型可能出錯。過往表現不代表未來結果。